Effect of Polyethylene Glycol 400 on Bile Excretion of Baicalin and Its Main Metabolite

Ya-nan ZHU; Shuo ZHANG; Min ZHANG; Peng-jiao WANG; Xiao-xia MENG; Xiu-li GAO

doi:10.13422/j.cnki.syfjx.20200653

您当前的位置：

首页 >

文章列表页 >

Effect of Polyethylene Glycol 400 on Bile Excretion of Baicalin and Its Main Metabolite

Drug Metabolism | 更新时间：2021-02-09

- Effect of Polyethylene Glycol 400 on Bile Excretion of Baicalin and Its Main Metabolite
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 10, Pages: 88-93(2020)
- 作者机构：
  
  贵州医科大学　药学院，省部共建药用植物功效与利用国家重点实验室，贵州省普通高等学校微生物与生化药学工程研究中心，贵阳　 550025
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20200653
  CLC： R22; R28; R94; C37; R969.1; O657
- Received：17 October 2019，
  
  Published Online：03 December 2019，
  
  Published：20 May 2020
- 稿件说明：
移动端阅览
Ya-nan ZHU, Shuo ZHANG, Min ZHANG, et al. Effect of Polyethylene Glycol 400 on Bile Excretion of Baicalin and Its Main Metabolite[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(10): 88-93.
DOI：

Ya-nan ZHU, Shuo ZHANG, Min ZHANG, et al. Effect of Polyethylene Glycol 400 on Bile Excretion of Baicalin and Its Main Metabolite[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(10): 88-93. DOI： 10.13422/j.cnki.syfjx.20200653.

摘要

目的：

考察药用辅料聚乙二醇400(PEG400)对黄芩苷及其主代谢物黄芩素6-

-葡萄糖醛酸苷(B6G)胆汁排泄的影响，并分析其作用机制。

方法：

大鼠随机分为黄芩苷＋水组与黄芩苷＋PEG400组，利用10%水合氯醛(剂量4 mL·kg

-1

)腹腔注射诱导麻醉，制作大鼠胆管插管模型，待大鼠完全清醒后，以168 mg·kg

-1

剂量的黄芩苷分别给大鼠灌胃相应的黄芩苷水溶液和黄芩苷PEG400溶液，收集给药后0～12 h的胆汁，使用UPLC-MS/MS测定不同时间段药物经胆汁排泄的浓度，采用Thermo Hypersil GOLD C

色谱柱(2.1 mm×100 mm，1.9 μm)，流动相乙腈(A)-0.1%甲酸水溶液(B)梯度洗脱(0～9 min，90%～27%B；9～10 min，27%～90%B；10～12 min，90%B)，流速0.3 mL·min

-1

，柱温30 ℃，进样量5 μL；质谱条件为电喷雾离子源(ESI)，正离子检测模式。利用体外孵育法和酶联免疫吸附测定(ELISA)研究PEG400对尿苷二磷酸葡萄糖醛酸转移酶(UGT)1A8和UGT1A9活性及二者在大鼠肝脏中表达的影响。

结果：

与黄芩苷＋水组相比，黄芩苷＋PEG400组大鼠12 h内胆汁中黄芩苷及其主代谢物B6G的累积排泄量分别增加了1.8，2.1倍；PEG400分别使UGT1A8与UGT1A9的酶活性提高了2.0，1.5倍，使肝脏中UGT1A8与UGT1A9的质量分数提高了2.2，1.3倍。

结论：

PEG400可通过提高UGT1A8与UGT1A9的活性和表达来显著增加黄芩苷及其主代谢物B6G的胆汁排泄，且对B6G胆汁排泄的促进作用大于原形药物黄芩苷，可为PEG400的临床合理应用及黄芩苷等黄酮类药物新剂型的设计提供依据。

Abstract

Objective:

To investigate the effect of polyethylene glycol 400 (PEG400) on rat bile excretion of baicalin and its main metabolite [baicalein 6-

-glucuronide (B6G)]

and to analyze its mechanism of action.

Method:

Rats were randomly divided into baicalin+ water group and baicalin+ PEG400 group

the anesthesia was induced by intraperitoneal injection of 10% chloral hydrate (dose of 4 mL·kg

-1

) to prepare a rat bile duct intubation model. After the rats were fully awake

rats were given baicalin aqueous solution and baicalin PEG400 solution with dose of 168 mg·kg

-1

for baicalin

respectively. And bile was collected from 0 h to 12 h after administration. UPLC-MS/MS was used to determine the concentration of drug excreted through bile at different time periods. Thermo Hypersil GOLD C

column was used with acetonitrile (A)-0.1% formic acid solution (B) as the mobile phase for gradient elution (0-9 min

90%-27%B; 9-10 min

27%-90%B; 10-12 min

90%B)

the flow rate was 0.3 mL·min

-1

the column temperature was 30 ℃

the injection volume was 5 μL. The mass spectra were obtained in positive ion mode with electrospray ionization (ESI). The effects of PEG400 on the activities and expressions in rat liver of uridine diphosphate glucuronyltransferase (UGT) 1A8 and UGT1A9 were studied

in vitro

incubation assay and enzyme linked immunosorbent assay (ELISA).

Result:

Compared with the baicalin+ water group

in the baicalin+ PEG400 group

the bile cumulative excretions of baicalin and B6G increased by 1.8 times and 2.1 times within 12 h

respectively. PEG400 increased the enzyme activities of UGT1A8 and UGT1A9 by 2.0 times and 1.5 times

and their concentrations in liver were increased by 2.2 times and 1.3 times

respectively.

Conclusion:

PEG400 can significantly increase the bile excretion of baicalin and its main metabolite B6G by enhancing the activities and expressions of UGT1A8 and UGT1A9

and its promoting effect on bile excretion of B6G is greater than that of baicalin

which provides a basis for the rational clinical application of PEG400 and the design of new dosage forms of flavonoids such as baicalin.

关键词

Keywords

references

W W LAI , J T JIA , B YAN , et al . Baicalin hydrate inhibits cancer progression in nasopharyngeal carcinoma by affecting genome instability and splicing [J]． Oncotarget ， 2017 ， 9 ( 1 )： 901 - 914 .

K H KIM , Y D PARK , H PARK , et al . Synthesis and biological evaluation of a novel baicalein glycoside as an anti-inflammatory agent [J]． Eur J Pharmacol ， 2014 ， 744 ： 147 - 156 .

W K TSANG , K Y CHAU , H P YANG ． Baicalein exhibits inhibitory effect on the energy-dependent efflux pump activity in non-albicans Candida fungi .[J]． J Chemotherapy ， 2015 ， 27 ( 1 )： 61 - 62 .

L GAO , J S FANG , X Y BAI , et al . In silico target fishing for the potential targets and molecular mechanisms of baicalein as an antiparkinsonian agent：discovery of the protective effects on NMDA receptor-mediated neurotoxicity [J]． Chem Biol Drug Des ， 2013 ， 81 ( 6 )： 675 - 687 .

蒋寅，刘军楼，朱磊，等．黄芩苷对HT-29细胞炎症模型PI3K/NF- κ B信号通路的影响及机制探讨 [J]．中国实验方剂学杂志， 2016 ， 22 ( 12 )： 118 - 122 .

邢杰．黄芩苷在动物体内的吸收和代谢研究 [D]．沈阳：沈阳药科大学， 2005 .

T AKAO , K KAWABATA , E YANAGISAWA ． Baicalin，the predominant flavone glucuronide of Scutellariae Radix，is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form [J]． J Pharm Pharmacol ， 2000 ， 52 ( 12 )： 1563 - 1568 .

B J WU , K KULKARNI , S BASU , et al . First-pass metabolism via UDP-glucuronosyltransferase：a barrier to oral bioavailability of phenolics [J]． J Pharm Sci ， 2011 ， 100 ( 9 )： 3655 - 3681 .

L ZHANG , G LIN , Z ZUO ． Involvement of UDP-glucuronosyltrans ferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein [J]． Pharm Res ， 2012 ， 24 ( 1 )： 81 - 89 .

L ZHANG , G LIN , B KOVACS , et al . Mechanistic study on the intestinal absorption and disposition of baicalein [J]． Eur J Pharm Sci ， 2013 ， 31 ( 3/4 )： 221 - 231 .

刘峥，周淑媛，李伟，等． Liguzinediol对正常大鼠离体心脏的正性肌力作用 [J]．中国新药与临床杂志， 2009 ， 28 ( 4 )： 293 - 296 .

K M GIACOMINI , S M HUANG , D J TWEEDIE , et al . Membrane transporters in drug development [J]． Nat Rev Drug Discov ， 2010 ， 9 ( 3 )： 215 - 236 .

K M HILLGREN , D KEPPLER , A A ZUR , et al . Emerging transporters of clinical importance：an update from the international transporter consortium [J]． Clin Pharmacol Ther ， 2013 ， 94 ( 1 )： 52 - 63 .

顾腾，张硕，张敏，等．菌群失调大鼠体内PEG400对黄芩苷和黄芩素药代动力学的影响 [J]．中国中药杂志， 2019 ， 44 ( 5 )： 1034 - 1040 .

Z ZHANG , G MA , C F XUE , et al . Establishment of rat liver microsome-hydrogel system for in vitro phase Ⅱ metabolism and its application to study pharmacological effects of UGT substrates [J]． Drug Metab Pharmacokinet ， 2019 ， 34 ( 2 )： 141 - 147 .

Y LI , H YUAN , K YANG , et al . The structure and functions of P-glycoprotein [J]． Curr Med Chem ， 2010 ， 17 ( 8 )： 786 - 800 .

黄建耿．药用辅料抑制肠道P-糖蛋白药泵作用研究 [D]．武汉：华中科技大学， 2008 .

M L ZHU , X L LIANG , L J ZHAO , et al . Elucidation of the transport mechanism of baicalin and the influence of a Radix Angelicae Dahuricae extract on the absorption of baicalin in a Caco-2 cell monolayer model [J]． J Ethnopharmacol ， 2013 ， 150 ( 2 )： 553 - 559 .

J MA , L ZHENG , T DENG , et al . Stilbene glucoside inhibits the glucuronidation of emodin in rats through the down-regulation of UDP-glucuronosyltransferases 1A8：application to a drug-drug interaction study in Radix Polygoni Multiflori [J]． J Ethnopharmacol ， 2013 ， 147 ( 2 )： 335 - 340 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Berberine-Baicalin Combination on Fecal Microbiota Transplantation-induced Type 2 Diabetes Mellitus Due to Internal Accumulation of Dampness-heat in Mice from Perspectives of Gut Microbiota and Metabolomics

Analysis on Metabolites and Metabolic Pathways of Harmine in Rats by UPLC-Q-TOF-MS

Baicalin Induces Ferroptosis in Gastric Cancer Cells via p53-mediated SLC7A11 Down-regulation

Investigation of Effect of Polyethylene Glycol 400 on Pharmacokinetics and Anti-inflammatory Effect of Baicalin Based on UPLC-MS/MS and Molecular Docking Techniques

Synergistic Effect of Baicalin and Wogonoside on NF-κB Signaling Pathway Based on Medium-efficiency Equation

Related Author

CHEN Mengjie

LIU Yimin

ZHOU Yun

YU Keming

XIA Min

LIU Hongning

JI Yanhua

ZENG Zhijun

Related Institution

Research Center for Differentiation and Development of Traditional Chinese Medicine （TCM） Basic Theory， Jiangxi Province Key Laboratory of TCM Etiopathogenisis， Jiangxi University of Chinese Medicine

State Key Laboratory of Pathogenesis， Prevention and Treatment of High Incidence Diseases in Central Asia， The First Affiliated Hospital of Xinjiang Medical University

Institute of Chinese Materia Medica， Shanghai University of Traditional Chinese Medicine

School of Pharmacy，Xinjiang Medical University

Henan Academy of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰